---
schema_version: "secwatch.filing_event.v1"
accession: "0001493152-23-040008"
form_type: "8-K"
ticker: "STXS"
cik: "0001289340"
company_name: "Stereotaxis, Inc."
filed_at: "2023-11-09T23:59:59+00:00"
generated_at: "2026-06-08T06:08:54.540470+00:00"
event_type: "earnings"
sentiment: "neutral"
materiality_score: 0.6
calibrated_materiality_score: 0.6
confidence: "high"
source: SEC EDGAR
---

# Stereotaxis Q3 revenue $7.8M (+1% YoY); net loss $5.4M; cash $23M, no debt

## Summary
- System revenue $3.5M from 2 Genesis systems; recurring revenue $4.3M (down 19% YoY, lost catheter royalties).
- Gross margin 52%; operating loss $5.6M vs $5.1M a year ago; adjusted operating loss $3.0M.
- Cash and equivalents $23.0M at Sept 30, 2023; no debt; negative free cash flow $1.0M in Q3.
- Expects to submit PMA supplement for MAGiC ablation catheter before year-end.
- System backlog $13M; expects continued revenue growth in coming quarters.

## SEC filing metadata
- accession: 0001493152-23-040008
- form_type: 8-K
- ticker: STXS
- cik: 0001289340
- company_name: Stereotaxis, Inc.
- filed_at: 2023-11-09T23:59:59+00:00
- event_type: earnings
- sentiment: neutral
- materiality_score: 0.6
- calibrated_materiality_score: 0.6
- confidence: high
- sec_items: 2.02, 9.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1289340/000149315223040008/0001493152-23-040008-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1289340/000149315223040008/form8-k.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001493152-23-040008
- JSON: https://secwatch.observer/filing/0001493152-23-040008.json
- Plain text: https://secwatch.observer/filing/0001493152-23-040008.txt

## Key facts
- Earnings Releases
  Stereotaxis, Inc. reported the third quarter ended September 30, 2023 results: revenue $7.8 million, net income ($5.4) million.
  - Period: the third quarter ended September 30, 2023
  - Revenue: $7.8 million
  - Net income: ($5.4) million
  - Result: reported results
  source text: Revenue for the third quarter of 2023 totaled $7.8 million, compared to $7.7 million in the prior year third quarter.
  evidence_url: https://www.sec.gov/Archives/edgar/data/1289340/000149315223040008/0001493152-23-040008-index.htm

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.
